Evaluation of Transition With a Heart, a Transition Program for Adolescents With Congenital Heart Disease and Parents
A Prospective Quasi-Experimental Study to Evaluate Transition With a Heart, a Transition Project for Adolescents With Congenital Heart Disease and Their Parents With Focus on Disease Knowledge and Transitional Skills
1 other identifier
interventional
81
1 country
1
Brief Summary
The department of Congenital Heart Disease of the Ghent University Hospital (Belgium) developed a transition program dedicated to adolescents with congenital heart disease (CHD): 'Transition With a Heart´ (TWAH). TWAH was developed based on the Dutch program 'On your own feet´, starting at the age of 12 years and continuing after transfer. The most vital core components include a general and individualized flowchart, adolescent-centred communication, a joined transfer consultation and an appointed transition coordinator. TWAH focuses on promoting disease knowledge, autonomy and skills development of adolescents with CHD. Interventions encompass the use of a communication-paper, autonomously talking to professionals, individualized education and skills development plan. Interventions were selected from the highest sources of scientific evidence currently available including (quasi-) experimental studies, narrative literature reviews and expert opinions. TWAH is the intervention in the conducted study. Hence, the intervention group are adolescents with CHD and their parents who are participating in TWAH. Adolescents and their parents who are transferred according to standard care (joined transfer consultation only) are identified as the control group and will be examined in the post test phase in order to be able to make comparisons with the intervention group. At baseline (the start of TWAH) participants of the control group already made the transfer to the adult ward. The investigators consider the following hypothetical scenario: \- TWAH will have a positive influence on disease knowledge and transition experiences of the participants.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Nov 2015
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
November 5, 2015
CompletedFirst Submitted
Initial submission to the registry
October 16, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2021
CompletedFirst Posted
Study publicly available on registry
July 29, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2022
CompletedJanuary 30, 2023
January 1, 2023
6.1 years
October 16, 2020
January 27, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Change in disease-related knowledge of adolescents of the intervention group (paired test)
Total knowledge score assesed by the Leuven Knowledge Questionnaire for Congenital Heart Disease (LKQCHD): and consists of 27 multiple choice questions for girls and 25 items for boys (Philip Moons et al., 2001). The total knowledge score consists of a ratio of the sum of correct answers to the total number of questions resulting in a 0-100 scale, where a higher score reflects a better disease-related knowledge.
At baseline (first transition outpatient visit around 14y) and through study completion, an average of 1 year from the transfer consultation
Comparison between disease-related knowledge scores of adolescents of the intervention group and adolescents of the control group
Total knowledge score assesed by the Leuven Knowledge Questionnaire for Congenital Heart Disease (LKQCHD): and consists of 27 multiple choice questions for girls and 25 items for boys (Philip Moons et al., 2001). The total knowledge score consists of a ratio of the sum of correct answers to the total number of questions resulting in a 0-100 scale, where a higher score reflects a better disease-related knowledge.
Through study completion, an average of 1 year from the transfer consultation
Secondary Outcomes (4)
Change in health-related quality of life of adolescents of the intervention group (paired test)
At baseline (first transition outpatient visit around 14y) and through study completion, an average of 1 year from the transfer consultation
Comparison between levels of health-related quality of life of adolescents of the intervention group and adolescents of the control group
Through study completion, an average of 1 year from the transfer consultation
Comparison of transfer experiences between adolescents of the intervention group and the adolescents of the control group
Through study completion, an average of 1 year from the transfer consultation
Comparison of transfer experiences between parents in the intervention group and control group
Through study completion, an average of 1 year from the transfer consultation
Study Arms (2)
Adolescents and their parent of the intervention group
EXPERIMENTALAdolescents and their parent who are participating in TWAH
Adolescents and their parent of the control group
NO INTERVENTIONAdolescents and their parent who are not participating in TWAH
Interventions
TWAH is a transition program, especially developed for adolescents with CHD and their parents. TWAH is starting at the age of 12 years and continuing after transfer. The most vital core components include a general and individualized flowchart, adolescent-centred communication, a joined transfer consultation and an appointed transition coordinator. TWAH focuses on promoting disease knowledge, autonomy and skills development of adolescents with CHD. Interventions encompass the use of a communication-paper, autonomously talking to professionals, individualized education and skills development plan. Details can be found in De Hosson et al, 2020 (1).
Eligibility Criteria
You may qualify if:
- Clinical diagnosis of a CHD of great or moderate complexity (6)
- From the age of 12 years or older
- Must be able to complete the questionnaires
- Dutch speaking AND/OR
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University Hospital, Ghentlead
- Universiteit Antwerpencollaborator
Study Sites (1)
Ghent University Hospital
Ghent, 9000, Belgium
Related Publications (4)
de Hosson M, De Backer J, De Wolf D, De Groote K, Demulier L, Mels S, Vandekerckhove K, Goossens E. Development of a transition program for adolescents with congenital heart disease. Eur J Pediatr. 2020 Feb;179(2):339-348. doi: 10.1007/s00431-019-03515-4. Epub 2019 Nov 22.
PMID: 31758312BACKGROUNDMoons P, De Volder E, Budts W, De Geest S, Elen J, Waeytens K, Gewillig M. What do adult patients with congenital heart disease know about their disease, treatment, and prevention of complications? A call for structured patient education. Heart. 2001 Jul;86(1):74-80. doi: 10.1136/heart.86.1.74.
PMID: 11410567BACKGROUNDvan Staa A, Sattoe JN. Young adults' experiences and satisfaction with the transfer of care. J Adolesc Health. 2014 Dec;55(6):796-803. doi: 10.1016/j.jadohealth.2014.06.008. Epub 2014 Aug 19.
PMID: 25149686BACKGROUNDWarnes CA, Liberthson R, Danielson GK, Dore A, Harris L, Hoffman JI, Somerville J, Williams RG, Webb GD. Task force 1: the changing profile of congenital heart disease in adult life. J Am Coll Cardiol. 2001 Apr;37(5):1170-5. doi: 10.1016/s0735-1097(01)01272-4. No abstract available.
PMID: 11300418BACKGROUND
Related Links
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- NONE
- Purpose
- HEALTH SERVICES RESEARCH
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
October 16, 2020
First Posted
July 29, 2022
Study Start
November 5, 2015
Primary Completion
December 1, 2021
Study Completion
December 1, 2022
Last Updated
January 30, 2023
Record last verified: 2023-01
Data Sharing
- IPD Sharing
- Will not share